John Greer MD
Hematologic Oncology
Professor, Medicine, Vanderbilt University School of Medicine
Join to View Full Profile
3601 21st Ave SNashville, TN 37232
Phone+1 615-322-3000
Fax+1 615-936-0605
Dr. Greer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1983 - 1984- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 1981 - 1983
Virginia Commonwealth University Health SystemResidency, Pediatrics, 1979 - 1981
Tulane UniversityResidency, Internal Medicine, 1976 - 1979
Vanderbilt University School of MedicineClass of 1976
Certifications & Licensure
TN State Medical License 1981 - 2022
LA State Medical License 1976 - 1981
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Tran...Dilan A Patel, Karina A. Mendoza, Heidi Chen, Brian G. Engelhardt, Bipin N. Savani
Journal of Hematology. 2021-02-06 - 2 citationsSeven decades of chemotherapy clinical trials: a pan-cancer social network analysisXuanyi Li, Elizabeth Sigworth, Adrianne H. Wu, Jess Behrens, Shervin A. Etemad
Scientific Reports. 2020-10-16 - 24 citationsOutcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.Frederick Lansigan, Steven M. Horwitz, Lauren C. Pinter-Brown, Steven T. Rosen, Barbara Pro
Acta Haematologica. 2020-01-01
Press Mentions
Magnet Designation Leader Downs Set to RetireAugust 25th, 2021- Opinion Imagining the World After COVID-19June 22nd, 2020
- Vanderbilt Poll: A Majority of Nashvillians Approve of Local LeadersApril 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
